You are here

  • Home
  • Archive
  • Volume 11, Issue 7
  • Correction: Nivolumab serum concentration in metastatic melanoma patients could be related to outcome and enhanced immune activity: a gene profiling retrospective analysis

Article metrics

Article menu

See original article:

Download PDFPDF

Correction
Correction: Nivolumab serum concentration in metastatic melanoma patients could be related to outcome and enhanced immune activity: a gene profiling retrospective analysis

 

Online download statistics by month:

Online download statistics by month: July 2023 to July 2025

AbstractFullPdf
Jul 2023020430
Aug 202309415
Sep 20230447
Oct 20230277
Nov 20230455
Dec 20230369
Jan 20240303
Feb 20240172
Mar 20240114
Apr 2024073
May 20240134
Jun 20240145
Jul 20240217
Aug 2024083
Sep 20240165
Oct 20240109
Nov 20240112
Dec 20240134
Jan 20250145
Feb 2025093
Mar 2025072
Apr 20250231
May 20250119
Jun 20250113
Jul 2025010
Total0697147